Cellectar Biosciences INC NEW
$2.590
USD
Last updated on --.
24h volume183.74K
24h highest2.7550 USD
24h lowest2.5200 USD
24h Price movement+0.00%
CLRB recent prices
24 Hours
+0.00%$0.00
30 days
-16.45%-$0.51
60 days
-6.16%-$0.17
90 days
-5.82%-$0.16
Key data
Previous close2.5900 USD
Market cap25.09M USD
Volume183.74K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.6100 USD
Net income (FY)-20.84M USD
Revenue (FY)--
Last report dateMay 14, 2026
About Cellectar Biosciences INC NEW
HeadquartersFLORHAM PARK
Employees (FY)11.00
Net income per employee (FY)-1.89M USD
Listed onNasdaq
CLRB conversion tables
 |  |
|---|---|
| 0.5 CLRB | 1.295 USD |
| 1 CLRB | 2.590 USD |
| 5 CLRB | 12.95 USD |
| 10 CLRB | 25.9 USD |
| |
|---|---|
| 0.5 USD | 0.19305 CLRB |
| 1 USD | 0.3861 CLRB |
| 5 USD | 1.930 CLRB |
| 10 USD | 3.861 CLRB |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CLRB is trading at $2.590, +0.00% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CLRB stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CLRB is currently trading at $2.590, +0.00% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CLRB price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CLRB's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CLRB; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CLRB's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Cellectar Biosciences INC NEW's market cap is currently 25.09M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume183.74K
24h highest2.7550 USD
24h lowest2.5200 USD
24h Price movement+0.00%
Start trade with CLRB Perpetual
Sign up to trade